Panavir is a pharmaceutical antiviral drug primarily used for the prevention and treatment of viral infections. It belongs to a class of drugs known as polysaccharides, derived from plant sources.
The main component of Panavir is a complex carbohydrate extracted from the shoots of the Solanaceae family of plants, primarily potato sprouts. The polysaccharides in Panavir have immunomodulatory and antiviral properties.
Panavir is known to be effective against a broad spectrum of viral infections, including herpes viruses, influenza viruses, papillomaviruses, and others. It works by inhibiting viral replication and stimulating immune responses in the body, thus helping to control and eradicate the viral infection.
The drug is available in various formulations such as injections, gels, ointments, and suppositories depending on the type of infection being treated. It is usually administered under medical supervision and the dosage depends on the severity and location of the viral infection.
Panavir has been extensively studied in clinical trials and has shown promising results in terms of reducing symptoms, shortening the duration of viral infections, and preventing recurrences. It is generally considered safe, and adverse effects are reported to be rare and mostly mild.
It is important to note that while Panavir has demonstrated antiviral effects, it is not a cure for viral infections, and its efficacy may vary depending on the specific virus and individual. Therefore, its use should be strictly prescribed and supervised by healthcare professionals.